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Main Text: 
 
We read with interest the article by Erdem et al. reporting absence of cerebrospinal fluid (CSF) 
pleocytosis (≤5 cells/l) in 3% (19/507) of HIV-negative tuberculous meningitis (TBM) patients (Erdem 
et al., 2017).  
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We wish to highlight both the significance and higher incidence of acellular CSF among HIV-infected 
adults with TBM. In reviewing 85 microbiologically-confirmed, HIV-associated TBM cases in Uganda, 
33% (28/85) had acellular CSF. Acellular CSF was also commonly reported among other HIV-infected 
microbiologically-confirmed TBM cohorts: 26% (5/19) in Zimbabwe, 19% (20/108) in Brazil, and 21% 
(18/91) in Argentina (Table1)(Cecchini et al., 2007, Croda et al., 2010, Hakim et al., 2000, Vidal et 
al., 2010). Prevalence of acellular CSF correlated with the severity of immunosuppression in the 
Argentinian cohort and occurred twice as often in CD4 counts <50 cells/l (33%, 9/28) than with >50 
cells/l (15%, 5/31) (Cecchini et al., 2009). In Vietnam, acellular CSF is less common (4%, 20/461) 
despite advanced immunosuppression (median CD4 39 cells/l). Variation between cohorts may be 
attributable to variable time to CSF analysis, M. tuberculosis strain type, or genetic differences in host 
immune responses between geographically distinct cohorts (Caws et al., 2008).  
 
In cryptococcal meningitis, both acellular CSF and elevated CSF neutrophil counts have been 
associated with poorer outcomes (Scriven et al., 2015). Recently, the observation of a paucity of 
inflammation or inappropriate neutrophil-mediated inflammation adversely impacting survival has also 
been confirmed in TBM. Thao et al. demonstrated that in Vietnamese adults lower CSF lymphocyte 
count was an independent predictor of mortality, regardless of HIV-status (Thao et al., 2017) and van 
Laarhoven et al. found that high CSF neutrophils were associated with death in a large Indonesian, 
predominantly HIV-negative, cohort (van Laarhoven et al., 2017).   
 
In HIV-infection, the degree of immunosuppression affects the intracerebral inflammatory phenotype.  
Those with CD4+ T-cell count <150 cells/μl had a higher median CSF neutrophil percentage than 
those with CD4+ count >150 cells/μl (25% versus 10%, P=0.021) and this correlated with higher CSF 
cytokine concentrations (Thuong et al., 2017).  Both increased CSF neutrophils and raised 
inflammatory mediator concentrations predispose to clinical deterioration after starting HIV therapy, 
resulting in higher morbidity and mortality (Marais S et al., CID 2014). This inflammation may 
contribute to the 44% mortality reported by Thuong in those with <150 CD4 cells/l compared with 
13% mortality in >150 CD4 cells/l.  Improved understanding of the drivers and consequences of the 
inflammatory phenotype in HIV-associated TBM may enable optimised use of adjunctive 
corticosteroids or host-directed therapy.  
 
“Typical” CSF findings (cells >5/l, protein >45g/l, glucose <45mg/dl) occur in under two-thirds of HIV-
infected TBM patients, so clinical acumen and highly sensitive diagnostic tests are critical (Croda et 
al., 2010). The new Xpert MTB/Rif ‘Ultra’ assay has greater analytical sensitivity and may reduce 
diagnostic dilemma in HIV-associated TBM (Bahr et al., 2018). These data should reinforce that 
acellular CSF is a poor prognostic sign and is relatively common among HIV-infected persons, 12% 
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(91/776) among the cohorts summarized. High clinical index of suspicion remains vital for timely, often 
empiric TBM therapy to reduce death and disability.  
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Table 1. Summary HIV-infected cohorts with microbiologically confirmed tuberculous 
meningitis 
 
 
 
Values represent N (%) or median (range). 
* microbiologically confirmed HIV-associated TBM cases from Thao et al. Vietnam cohort included  
N/A is not data available 
a “Normal CSF” defined as white cells <5/mm3, protein <45g/l, glucose >45mg/dl (2.5mmol/l).  b CSF data 
available for n=19. c CSF data available for n=91. d CSF data available for 458. e outcome known for n=69.  
 
 
Cohort Uganda 
Zimbabwe 
(Hakim et al.) 
Brazil 
(Croda et al.) 
Argentina 
(Cecchini et al.) 
Vietnam 
(Thao et al.)* 
Study Period 2011 - 2017 1994 1999-2007 1996-2004 2004-2015 
N 85 21 108 101 461 
Median CD4 cells/l 81 131 65  53 39 
CSF lymphocytes /mm3 75 (0-2450) N/A 49 (0-100) N/A 103 (0-6004) 
Acellular CSF with <5 cells/l 28 (33%) 5 (26%)b 20 (19%) 18 (21%)c 20 (4%)d 
Normal CSF (white cells, 
protein and glucose)a 
3 (4%) 0 (0%) 4 (4%) N/A 
2 (0.4%) 
In hospital Mortality  54% e 67% 29% 63%  N/A 
9-month Mortality N/A N/A 41% N/A 51% 
Mortality in patients with 
acellular CSF 
39% N/A 55% N/A 
60% 
Mortality in patients with 
normal CSF 
0% N/A 75% N/A 
100% 
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